Shin Nippon Biomedical Laboratories, Ltd. 2395

Satsuma Pharmaceuticals, Inc., a biopharmaceutical company focused on advancing innovative treatments for people living with migraine, today announced that two abstracts highlighting findings from its clinical development program have been selected for presentation at the American Headache Society's (AHS) 68th Annual Scientific Meeting. The meeting will take place June 4 - 7, 2026, at the Orlando World Center Marriott in Orlando, Florida, with both in-person and virtual attendance options availa